Results 321 to 330 of about 950,946 (355)

Genetic Adjuvants

2003
In 1992, the era of DNA vaccines began with the report of antibody production upon intradermal injection of mice with a plasmid vector expressing a foreign antigen (1). A rapid succession of subsequent manuscripts showed stimulation of immune responses, including cytolytic T cells, upon inoculation of expression-vectors specific for antigens derived ...
H C, Ertl, S, Pasquini, Z, He, H, Deng, L, Showe, W, Giles-Davis, Y, Wang, I, O, H, Marston, M, Blaszczyk-Thurin, Z, Xiang   +10 more
openaire   +2 more sources

[Adjuvants].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2017
It is estimated that only 5% of all patients who can principally benefit from specific immunotherapy (SIT) undergo this treatment. SIT represents the only curative treatment for allergic disorders and efficacy has been demonstrated with various allergens.
openaire   +3 more sources

Adjuvant Chemotherapy for Breast Cancer

Ca-A Cancer Journal for Clinicians, 1985
Grant W Hennig
exaly   +8 more sources

ADJUVANTS

Annals of the New York Academy of Sciences, 1974
openaire   +2 more sources

Immunological Adjuvants

1992
A C, Allison, N E, Byars
openaire   +2 more sources

Adjuvant Chemotherapy

2009
M, Tubiana-Hulin, M, Gardner
openaire   +2 more sources

Aromatase Inhibitors as Adjuvant Therapy for Postmenopausal Patients With Early Stage Breast Cancer

Ca-A Cancer Journal for Clinicians, 2005
Ruth M O'regan
exaly  

Adjuvant Treatment of Colorectal Cancer

Ca-A Cancer Journal for Clinicians, 2007
Brian M Wolpin, Harvey J Mamon, Jeffrey A Meyerhardt   +2 more
exaly  

Highlights from recent National Surgical Adjuvant Breast and Bowel Project studies in the treatment and prevention of breast cancer

Ca-A Cancer Journal for Clinicians, 1999
Eleftherios P Mamounas
exaly  

Current status of adjuvant systemic therapy for primary breast cancer: progress and controversy

Ca-A Cancer Journal for Clinicians, 1995
Gabriel N Hortobagyi
exaly